There are contraindications! Be sure to consult your doctor before taking any medication!
Flutaplex - An antiandrogen with about the same potency as cyproterone in rodent and canine species.
Indication: For the management of locally confined Stage B2-C and Stage D2 metastatic carcinoma of the prostate
Flutaplex is a nonsteroidal antiandrogen. In animal studies, Flutaplex demonstrates potent antiandrogenic effects. It exerts its antiandrogenic action by inhibiting androgen uptake and/or by inhibiting nuclear binding of androgen in target tissues or both. Prostatic carcinoma is known to be androgen-sensitive and responds to treatment that counteracts the effect of androgen and/or removes the source of androgen, e.g. castration. Elevations of plasma testosterone and estradiol levels have been noted following Flutaplex administration.
Pharmaceutical active ingredients containing related brand and generic drugs, medications or other health care products: